AmberHealth Review

AmberHealth in one line: the price is the pitch

AmberHealth is built around a single idea — make compounded GLP-1 therapy cost as little as possible and get out of the way. At $100 a month for compounded semaglutide, it lands among the cheapest options we track, well under the category median of $170. If your whole reason for going the telehealth route is to pay less than a high three-figure brand list price, AmberHealth is squarely aimed at you. What you trade for that price is transparency: it publishes far less about how the program actually runs than most of its rivals.

How the flat-rate pricing actually works

The pricing model is genuinely simple, and that simplicity is the point. AmberHealth charges a flat monthly rate that does not climb as your dose climbs. On its own site the company states plainly that 'all dosages are the same price' — so the $100 semaglutide rate you pay during titration is the same rate you pay once you reach a maintenance dose. That is a real advantage over the many providers whose monthly bill quietly increases every time you step up, and it makes budgeting painless.

That flat rate is also bundled. AmberHealth says your monthly price includes the medication itself, your doctor consultations, shipping, ongoing clinical support, and dosage adjustments — no separate consult charge, no shipping surcharge, no upcharge to talk to a prescriber when you need a tweak. For a budget shopper, an all-in number with no add-ons is exactly what you want, because surprise fees are where 'cheap' telehealth usually stops being cheap.

The medications: compounded semaglutide and tirzepatide, both with B12

AmberHealth offers two molecules: compounded semaglutide and compounded tirzepatide, each formulated with added B12 (a common pairing meant to help blunt early nausea). Tirzepatide carries a modest premium over the semaglutide rate but still comes in below what most competitors charge for the same drug. Both are compounded — not the brand-name pens — which is how the price gets this low.

It is worth being clear-eyed about what compounded means here. These are not FDA-approved finished products like Wegovy or Zepbound; they are made by compounding pharmacies. AmberHealth does not publicly name its compounding pharmacy or list any pharmacy accreditation in the record we verified, which is the single biggest information gap for a careful buyer. If pharmacy provenance matters to you — and for an injectable medication, it reasonably should — you will have to ask them directly before you commit.

A platform, not a pharmacy

The detail that most defines AmberHealth is structural: it describes itself as a technology platform that connects patients with independent prescribers rather than a clinic that employs doctors or a pharmacy that dispenses medication. The company markets '1000+ physicians' and 'board-certified doctors available in all 50 states,' and that nationwide footprint is a genuine strength — coverage in all 50 states is not a given in this space.

But the platform model cuts both ways. Because AmberHealth sits between you and an independent prescriber, the continuity of care can feel thinner than at a provider that owns the whole experience. You may not see the same clinician each time, and accountability for the medication is split across parties. That is a fair trade for the price for many people, but you should know the shape of what you are buying.

Who should choose it — and who should skip it

• Choose AmberHealth if: your top priority is the lowest realistic monthly cost, you want a flat rate that won't rise as your dose increases, you're comfortable with compounded medication, and you value an all-in bundle with no add-on fees.
• Skip it if: you want a named, accreditation-verified compounding pharmacy disclosed up front; you need a documented, consistent relationship with one clinician; or you'd rather pay more for a provider that publishes detailed program terms, refund policies, and oversight information.

Trust, safety, and what we couldn't verify

On the reassuring side, there are no FDA warning letters on file for AmberHealth in our record, and its core claims — flat pricing, the bundled inclusions, nationwide prescriber access — were verified live on its own site. There is nothing here that contradicts itself or oversells.

On the cautious side, our verification confidence is held back by how little AmberHealth discloses: no named pharmacy, no published accreditation, and limited public detail on refund terms, cancellation, or what happens if a dose doesn't work for you. That's not evidence of a problem — it's an absence of information, and for a medical product that absence is itself worth weighing. We'd treat the program details as 'confirm before you buy' rather than 'documented and settled.' You can see how we weigh these factors in our scoring methodology.

Bottom line

AmberHealth does one thing very well: it makes compounded semaglutide and tirzepatide about as affordable as this market gets, with a flat, all-inclusive rate and 50-state access. The catch is thin public transparency — especially around the pharmacy behind the medication. If you're a price-first shopper who's comfortable asking a few pointed questions before signing up, it's a strong value. If you want every detail documented before you hand over a credit card, you'll be more comfortable paying a little more elsewhere.

If you're weighing alternatives, bmiMD ($99/month) is one of the closest options we track to AmberHealth.